SCHEMBL1005265

SCHEMBL1005265

CCCCCCC(CCC)Oc1cc[c]cc1

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 2/20 0.36
ALDH1A1 P00352 1/20 0.33
NR5A1 Q13285 1/20 0.32
CTRC Q99895 1/20 0.31
PRSS1 P07477 1/20 0.31
PRSS2 P07478 1/20 0.31
PRSS3 P35030 1/20 0.31
PLA2G2A P14555 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28811118 1.00 SLC2A1 (0.36) SLC2A1ALDH1A1NR5A1CTRCPRSS1
SCHEMBL1007342 1.00 SLC2A1 (0.36) SLC2A1ALDH1A1NR5A1CTRCPRSS1
SCHEMBL9116637 1.00 SLC2A1 (0.36) SLC2A1ALDH1A1NR5A1CTRCPRSS1
SCHEMBL1005061 0.89 PPARG (0.30)
SCHEMBL27574110 0.88 SLC2A1 (0.33) SLC2A1ALDH1A1CTRCPRSS1PRSS2
SCHEMBL9001273 0.84 SLC2A1 (0.46) SLC2A1NR5A1CTRCPLA2G2A
SCHEMBL28997989 0.83 LTA4H (0.43) SLC2A1ALDH1A1CTRCPRSS1PRSS2
SCHEMBL28280512 0.83 LTA4H (0.43) SLC2A1ALDH1A1CTRCPRSS1PRSS2
SCHEMBL28013972 0.83 LTA4H (0.43) SLC2A1ALDH1A1CTRCPRSS1PRSS2
SCHEMBL29239852 0.83 PRKCA (0.35) SLC2A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10777809-B2 Method for producing negative electrode active material for lithium ion secondary batteries JNC CORPORATION (JP) 2020-09-15 US disclosed
EP-3442060-B1 METHOD FOR PRODUCING NEGATIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES JNC CORP (JP) 2020-06-03 EP disclosed
US-20190131621-A1 METHOD FOR PRODUCING NEGATIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES JNC CORPORATION (JP) 2019-05-02 US disclosed
EP-3442060-A1 METHOD FOR PRODUCING NEGATIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES JNC Corporation (JP) 2019-02-13 EP disclosed
CN-109314235-A Method for producing negative electrode active material for lithium ion secondary battery 捷恩智株式会社 2019-02-05 CN disclosed
EP-1548020-B1 SILICON COMPOUND JNC CORP (JP) 2014-07-23 EP disclosed
EP-1550664-B1 SILICON COMPOUND JNC CORP (JP) 2012-06-27 EP disclosed
US-7964692-B2 Polymer obtained by addition-polymerization initiated by a silicon compound JNC CORPORATION (JP) 2011-06-21 US disclosed
US-7863396-B2 Silicon compounds CHISSO CORPORATION (JP) 2011-01-04 US disclosed
US-7662985-B2 Polysilsesquioxanes; addition-condensation copolymers CHISSO CORPORATION (JP) 2010-02-16 US disclosed
US-20060175684-A1 Organosilicon compound JNC PETROCHEMICAL CORPORATION (JP) 2006-08-10 US disclosed
EP-1686133-A2 Organosilicon compound CHISSO CORPORATION (JP) 2006-08-02 EP disclosed
US-20060094849-A1 Silicon compound JNC CORPORATION (JP) 2006-05-04 US disclosed
EP-1650214-A2 Silicon compound CHISSO CORPORATION (JP) 2006-04-26 EP disclosed
US-20050288468-A1 Cyclic polysilsequisiloxanes substituted with a group containing a sulfonyl halide, especially ahalosulfonylphenyl group; living radical polymerization initiators, particularly for preparing acrylic polymers JNC CORPORATION (JP) 2005-12-29 US disclosed
US-20050250925-A1 Silicon compound JNC CORPORATION (JP) 2005-11-10 US disclosed
EP-1550664-A1 SILICON COMPOUND CHISSO CORPORATION (JP) 2005-07-06 EP disclosed
EP-1548020-A1 SILICON COMPOUND CHISSO CORPORATION (JP) 2005-06-29 EP disclosed
US-20050033077-A1 Production process for silicon compound and the same JNC CORPORATION (JP) 2005-02-10 US disclosed
US-20040143081-A1 Novel silicon compounds and process for preparation thereof JNC CORPORATION (JP) 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288468-A1 Cyclic polysilsequisiloxanes substituted with a group containing a sulfonyl halide, especially ahalosulfonylphenyl group; living radical polymerization initiators, particularly for preparing acrylic polymers STS, SULT1A1, SRM SLC2A1 186/4885ALDH1A1 384/4885NR5A1 2461/4885
US-20050033077-A1 Production process for silicon compound and the same STS, SMS, SFXN1 SLC2A1 1011/4885ALDH1A1 1081/4885NR5A1 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.